Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2003
|
| gptkbp:ATCCode |
gptkb:C10AA07
|
| gptkbp:availableOn |
gptkb:tablet
|
| gptkbp:CASNumber |
287714-41-4
|
| gptkbp:chemicalFormula |
C22H28FN3O6S
|
| gptkbp:contraindication |
gptkb:liver_disease
pregnancy breastfeeding |
| gptkbp:drugClass |
statin
|
| gptkbp:eliminationHalfLife |
19 hours
|
| gptkbp:excretion |
urine
feces |
| gptkbp:genericName |
gptkb:rosuvastatin
|
| https://www.w3.org/2000/01/rdf-schema#label |
Crestor
|
| gptkbp:indication |
gptkb:familial_hypercholesterolemia
hyperlipidemia prevention of cardiovascular events |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:AstraZeneca
|
| gptkbp:mechanismOfAction |
HMG-CoA reductase inhibitor
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
X
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
abdominal pain headache muscle pain |
| gptkbp:usedFor |
lowering cholesterol
reducing risk of cardiovascular disease |
| gptkbp:bfsParent |
gptkb:AstraZeneca
|
| gptkbp:bfsLayer |
5
|